Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 189

Similar articles for PubMed (Select 23285161)

1.

Clinical significance and role of lymphatic vessel invasion as a major prognostic implication in non-small cell lung cancer: a meta-analysis.

Wang J, Wang B, Zhao W, Guo Y, Chen H, Chu H, Liang X, Bi J.

PLoS One. 2012;7(12):e52704. doi: 10.1371/journal.pone.0052704. Epub 2012 Dec 20.

2.

Blood vessel invasion as a strong independent prognostic indicator in non-small cell lung cancer: a systematic review and meta-analysis.

Wang J, Chen J, Chen X, Wang B, Li K, Bi J.

PLoS One. 2011;6(12):e28844. doi: 10.1371/journal.pone.0028844. Epub 2011 Dec 14. Review.

3.

Blood vessel and lymphatic vessel invasion in resected nonsmall cell lung carcinoma. Correlation with TNM stage and disease free and overall survival.

Bréchot JM, Chevret S, Charpentier MC, Appere de Vecchi C, Capron F, Prudent J, Rochemaure J, Chastang C.

Cancer. 1996 Nov 15;78(10):2111-8.

PMID:
8918404
4.

Prognostic impact of lymphovascular invasion compared with that of visceral pleural invasion in patients with pN0 non-small-cell lung cancer and a tumor diameter of 2 cm or smaller.

Tao H, Hayashi T, Sano F, Takahagi A, Tanaka T, Matsuda E, Okabe K.

J Surg Res. 2013 Nov;185(1):250-4. doi: 10.1016/j.jss.2013.05.104. Epub 2013 Jun 22.

PMID:
23830361
5.

Lymphatic vessel invasion is a significant prognostic indicator in stage IA lung adenocarcinoma.

Funai K, Sugimura H, Morita T, Shundo Y, Shimizu K, Shiiya N.

Ann Surg Oncol. 2011 Oct;18(10):2968-72. doi: 10.1245/s10434-011-1729-9. Epub 2011 Apr 22.

PMID:
21512862
6.

Lymphovascular invasion in non-small-cell lung cancer: implications for staging and adjuvant therapy.

Higgins KA, Chino JP, Ready N, D'Amico TA, Berry MF, Sporn T, Boyd J, Kelsey CR.

J Thorac Oncol. 2012 Jul;7(7):1141-7. doi: 10.1097/JTO.0b013e3182519a42.

PMID:
22617241
7.

Lymphovascular invasion as a prognostic indicator in stage I non-small cell lung cancer: a systematic review and meta-analysis.

Mollberg NM, Bennette C, Howell E, Backhus L, Devine B, Ferguson MK.

Ann Thorac Surg. 2014 Mar;97(3):965-71. doi: 10.1016/j.athoracsur.2013.11.002. Epub 2014 Jan 11. Review.

PMID:
24424014
8.

Local recurrence after surgery for non-small cell lung cancer: a recursive partitioning analysis of multi-institutional data.

Kelsey CR, Higgins KA, Peterson BL, Chino JP, Marks LB, D'Amico TA, Varlotto JM.

J Thorac Cardiovasc Surg. 2013 Oct;146(4):768-773.e1. doi: 10.1016/j.jtcvs.2013.05.041. Epub 2013 Jul 13.

PMID:
23856204
9.

The prognostic value of epigenetic silencing of p16 gene in NSCLC patients: a systematic review and meta-analysis.

Lou-Qian Z, Rong Y, Ming L, Xin Y, Feng J, Lin X.

PLoS One. 2013;8(1):e54970. doi: 10.1371/journal.pone.0054970. Epub 2013 Jan 25. Review.

10.

The prognostic significance of lymphovascular invasion on biopsy specimens in lung cancer treated with definitive chemoradiotherapy.

Massabeau C, Filleron T, Wakil G, Rouquette I, Bachaud JM, Leguellec S, Delisle MB, Toulas C, Mazieres J, Cohen-Jonathan Moyal E.

Clin Lung Cancer. 2012 Jan;13(1):59-67. doi: 10.1016/j.cllc.2011.06.011.

PMID:
21856239
11.

Prognostic significance of lymphovascular invasion for patients with stage I non-small cell lung cancer.

Hanagiri T, Takenaka M, Oka S, Shigematsu Y, Nagata Y, Shimokawa H, Uramoto H, Yamada S, Tanaka F.

Eur Surg Res. 2011;47(4):211-7. doi: 10.1159/000333367. Epub 2011 Oct 21.

PMID:
22025080
12.

Expression of p16 in non-small cell lung cancer and its prognostic significance: a meta-analysis of published literatures.

Tong J, Sun X, Cheng H, Zhao D, Ma J, Zhen Q, Cao Y, Zhu H, Bai J.

Lung Cancer. 2011 Nov;74(2):155-63. doi: 10.1016/j.lungcan.2011.04.019. Epub 2011 May 31.

PMID:
21621871
13.

Study of prognostic predictors for non-small cell lung cancer.

Fu XL, Zhu XZ, Shi DR, Xiu LZ, Wang LJ, Zhao S, Qian H, Lu HF, Xiang YB, Jiang GL.

Lung Cancer. 1999 Feb;23(2):143-52.

PMID:
10217618
14.

Prognostic value of K-RAS mutations in patients with non-small cell lung cancer: a systematic review with meta-analysis.

Meng D, Yuan M, Li X, Chen L, Yang J, Zhao X, Ma W, Xin J.

Lung Cancer. 2013 Jul;81(1):1-10. doi: 10.1016/j.lungcan.2013.03.019. Epub 2013 Apr 19. Review.

PMID:
23608713
15.

D2-40-positive lymphatic vessel invasion is not a poor prognostic factor in stage I lung adenocarcinoma.

Shimizu K, Funai K, Sugimura H, Sekihara K, Kawase A, Shiiya N.

Pathol Int. 2013 Apr;63(4):201-5. doi: 10.1111/pin.12048.

PMID:
23692420
16.

[Prognostic value of lymphangiogenesis and lymphatic vessel invasion in non-small cell lung cancer].

Hu Z, Wang W, Zhang J, Mao F, Shen-Tu Y.

Zhongguo Fei Ai Za Zhi. 2012 Nov;15(11):656-62. doi: 10.3779/j.issn.1009-3419.2012.11.09. Chinese.

17.

Lymphatic microvessel density as a prognostic factor in non-small cell lung carcinoma: a meta-analysis of the literature.

Wang J, Li K, Wang B, Bi J.

Mol Biol Rep. 2012 May;39(5):5331-8. doi: 10.1007/s11033-011-1332-y. Epub 2011 Dec 14.

PMID:
22167333
18.

Pathological vascular invasion and tumor differentiation predict cancer recurrence in stage IA non-small-cell lung cancer after complete surgical resection.

Shimada Y, Saji H, Yoshida K, Kakihana M, Honda H, Nomura M, Usuda J, Kajiwara N, Ohira T, Ikeda N.

J Thorac Oncol. 2012 Aug;7(8):1263-70. doi: 10.1097/JTO.0b013e31825cca6e.

PMID:
22673056
19.

A meta-analysis of STAT3 and phospho-STAT3 expression and survival of patients with non-small-cell lung cancer.

Xu YH, Lu S.

Eur J Surg Oncol. 2014 Mar;40(3):311-7. doi: 10.1016/j.ejso.2013.11.012. Epub 2013 Dec 4. Review.

PMID:
24332948
20.

The prognostic value of RASSF1A promoter hypermethylation in non-small cell lung carcinoma: a systematic review and meta-analysis.

Wang J, Wang B, Chen X, Bi J.

Carcinogenesis. 2011 Mar;32(3):411-6. doi: 10.1093/carcin/bgq266. Epub 2010 Dec 14.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk